Elon Musk’s Neuralink closes a $650M Series E

Neuralink, the brain-computer interface company founded by Elon Musk, has successfully completed a Series E funding round, raising an impressive $650 million, as revealed in a recent blog post. This funding round attracted notable investors, including ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others. Previously, Neuralink had raised $280 million in a Series D round in 2023, followed by an extra $43 million shortly thereafter. The company has made significant progress in its brain chip technology, having conducted human clinical trials by implanting its devices in five individuals suffering from severe paralysis. In May, Neuralink achieved a major milestone by receiving breakthrough device designation from the U.S. Food and Drug Administration, which aims to expedite the development and review of innovative technologies. According to Semafor, this latest funding round values Neuralink at approximately $9 billion before accounting for the new investment.